Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bu Fei Yi Shen granules for stable COPD (phase II)
CTR20263079Phase 2Active
- Sponsor
- Institute of Chinese Materia Medica
- Start
- Aug 2026
- Countries
- 1
01
Overview
A Phase 2 trial of bufei yishen granule in chronic obstructive pulmonary disease (COPD), sponsored by Institute of Chinese Materia Medica. Started Aug 2026; status: active.
02
Drugs
bufei yishen granule
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20263079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263079.